GlobeStar Therapeutics Co. (OTCMKTS:GSTC) Short Interest Update

GlobeStar Therapeutics Co. (OTCMKTS:GSTC) saw a significant decline in short interest in March. As of March 31st, there was short interest totalling 3,100 shares, a decline of 90.6% from the March 15th total of 33,100 shares. Based on an average daily volume of 2,003,300 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are sold short.

GlobeStar Therapeutics Stock Up 50.0 %

OTCMKTS:GSTC traded up $0.00 during mid-day trading on Monday, hitting $0.00. 8,815,019 shares of the stock traded hands, compared to its average volume of 3,169,651. GlobeStar Therapeutics has a 12-month low of $0.00 and a 12-month high of $0.00.

About GlobeStar Therapeutics

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc and changed its name to GlobeStar Therapeutics Corporation in July 2021.